Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Fendly

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Biology|March 1, 1989
p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factorR M Hudziak, G D Lewis, M Winget, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunityM N Teng, B H Park, H K Koeppen, et al.
The Journal of Clinical Investigation|December 1, 1993
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progressionC L Arteaga, S D Hurd, A R Winnier, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|June 1, 1990
Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell cultureS M Kramer, U E Gibson, B M Fendly, et al.
International Journal of Cancer|March 15, 1990
Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissuesP G Natali, M R Nicotra, A Bigotti, et al.
Oncogene|July 1, 1994
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cellsR J Pietras, B M Fendly, V R Chazin, et al.
Seminars in Oncology|September 11, 1999
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)M X Sliwkowski, J A Lofgren, G D Lewis, et al.
The Journal of Biological Chemistry|August 15, 1997
Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sitesK H Pearce, B J Potts, L G Presta, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesisA Ashkenazi, L G Presta, S A Marsters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1990
The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISAC Lucas, L N Bald, B M Fendly, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Biology|March 1, 1989
p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factorR M Hudziak, G D Lewis, M Winget, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunityM N Teng, B H Park, H K Koeppen, et al.
The Journal of Clinical Investigation|December 1, 1993
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progressionC L Arteaga, S D Hurd, A R Winnier, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|June 1, 1990
Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell cultureS M Kramer, U E Gibson, B M Fendly, et al.
International Journal of Cancer|March 15, 1990
Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissuesP G Natali, M R Nicotra, A Bigotti, et al.
Oncogene|July 1, 1994
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cellsR J Pietras, B M Fendly, V R Chazin, et al.
Seminars in Oncology|September 11, 1999
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)M X Sliwkowski, J A Lofgren, G D Lewis, et al.
The Journal of Biological Chemistry|August 15, 1997
Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sitesK H Pearce, B J Potts, L G Presta, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesisA Ashkenazi, L G Presta, S A Marsters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1990
The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISAC Lucas, L N Bald, B M Fendly, et al.
Pageof 5